Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2006 3
2007 1
2008 3
2009 1
2010 4
2011 2
2012 1
2013 1
2014 4
2015 7
2016 8
2017 4
2018 1
2019 2
2020 8
2021 6
2022 3
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
Weitz JI, Lensing AWA, Prins MH, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Freitas MCS, Holberg G, Kakkar AK, Haskell L, van Bellen B, Pap AF, Berkowitz SD, Verhamme P, Wells PS, Prandoni P; EINSTEIN CHOICE Investigators. Weitz JI, et al. N Engl J Med. 2017 Mar 30;376(13):1211-1222. doi: 10.1056/NEJMoa1700518. Epub 2017 Mar 18. N Engl J Med. 2017. PMID: 28316279 Free article. Clinical Trial.
Apixaban-induced hepatotoxicity.
Cordeanu M, Lambert A, Gaertner S, Nouri S, Mirea C, Alt-Tebacher M, Stephan D. Cordeanu M, et al. Among authors: stephan d. Int J Cardiol. 2016 Feb 1;204:4-5. doi: 10.1016/j.ijcard.2015.11.147. Epub 2015 Nov 23. Int J Cardiol. 2016. PMID: 26649445 Review. No abstract available.
[Ovarian-vein thrombosis].
Stephan D, Gaertner S, Miréa C, Marescaux J, Aleil B. Stephan D, et al. Presse Med. 2012 May;41(5):550-1. doi: 10.1016/j.lpm.2011.07.022. Epub 2011 Nov 21. Presse Med. 2012. PMID: 22104485 French. No abstract available.
[Retroperitoneal fibrosis].
Gaertner S, Cordeanu EM, Mirea C, Stephan D. Gaertner S, et al. Among authors: stephan d. Presse Med. 2014 Sep;43(9):1021-3. doi: 10.1016/j.lpm.2014.02.019. Epub 2014 May 23. Presse Med. 2014. PMID: 24863664 French. No abstract available.
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE.
Turpie AGG, Farjat AE, Haas S, Ageno W, Weitz JI, Goldhaber SZ, Goto S, Angchaisuksiri P, Kayani G, Lopes RD, Chiang CE, Gibbs H, Tse E, Verhamme P, Ten Cate H, Muntaner J, Schellong S, Bounameaux H, Prandoni P, Maheshwari U, Kakkar AK; GARFIELD-VTE investigators. Turpie AGG, et al. Thromb Res. 2023 Feb;222:31-39. doi: 10.1016/j.thromres.2022.11.016. Epub 2022 Nov 25. Thromb Res. 2023. PMID: 36565677 Free article.
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial.
Zuily S, Lefèvre B, Sanchez O, Empis de Vendin O, de Ciancio G, Arlet JB, Khider L, Terriat B, Greigert H, Robert CS, Louis G, Trinh-Duc A, Rispal P, Accassat S, Thiery G, Montani D, Azarian R, Meneveau N, Soudet S, Le Mao R, Maurier F, Le Moing V, Quéré I, Yelnik CM, Lefebvre N, Martinot M, Delrue M, Benhamou Y, Parent F, Roy PM, Presles E, Goehringer F, Mismetti P, Bertoletti L, Rossignol P, Couturaud F, Wahl D, Thilly N, Laporte S; COVI-DOSE investigators. Zuily S, et al. EClinicalMedicine. 2023 Jun;60:102031. doi: 10.1016/j.eclinm.2023.102031. Epub 2023 Jun 9. EClinicalMedicine. 2023. PMID: 37350990 Free PMC article.
Statins and prevention of venous thromboembolism: Myth or reality?
Gaertner S, Cordeanu EM, Nouri S, Mirea C, Stephan D. Gaertner S, et al. Among authors: stephan d. Arch Cardiovasc Dis. 2016 Mar;109(3):216-22. doi: 10.1016/j.acvd.2015.11.007. Epub 2016 Jan 14. Arch Cardiovasc Dis. 2016. PMID: 26778087 Free article. Review.
Inhibition of thrombin-activatable fibrinolysis inhibitor via DS-1040 to accelerate clot lysis in patients with acute pulmonary embolism: a randomized phase 1b study.
Vanassche T, Rosovsky RP, Moustafa F, Büller HR, Segers A, Patel I, Shi M, Miyoshi N, Mani V, Fayad Z, Stephan D, Schmidt J, Grosso MA, Tapson VF, Verhamme P, Huisman MV; of the DS-1040 Study Group. Vanassche T, et al. Among authors: stephan d. J Thromb Haemost. 2023 Oct;21(10):2929-2940. doi: 10.1016/j.jtha.2023.04.037. Epub 2023 May 11. J Thromb Haemost. 2023. PMID: 37178771 Clinical Trial.
60 results